Pharmaceutical intelligence platform combining SEC insider filings, USPTO trademarks, NIH grants, and sentiment analysis to surface signals before the market reacts.
Beacon aggregates and analyzes alternative data sources to identify early signals in pharmaceutical development, regulatory activity, and competitive positioning. Our platform helps investors and strategists stay ahead of market-moving events.
Beacon is currently in private beta. Join our waitlist to get early access and exclusive launch pricing when we open to subscribers.
Request Early Access